Rigshospitalet, Denmark: Carcinoma, Non-Small-Cell Lung trials
The registry lists 13 Carcinoma, Non-Small-Cell Lung studies with Rigshospitalet, Denmark as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 3No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /SegmentectomyRecruitingNCT07213375Phase 2/3
- Copenhagen Master Observational TrialRecruitingNCT05145244
- Mobilization Before and After Video-Assisted Thoracoscopic Surgery Lobectomy/SegmentectomyCompletedNCT07338474
- Why in Hospital After VATS LobectomyCompletedNCT04294108
- Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive TherapyCompletedNCT03740126Not applicable
- WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLCStatus unknownNCT03481101Not applicable
- Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung CancerStatus unknownNCT03066271Not applicable
- FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung CancerCompletedNCT02995889Not applicable
- Suction on Post-Operative Chest TubesCompletedNCT02911259Not applicable
- uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the LungStatus unknownNCT02755675Phase 2
- Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for ChemotherapyTerminatedNCT00452075Phase 2
- Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3TerminatedNCT00273507Phase 3
- Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2Status unknownNCT00273494Phase 3